Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

492 results

TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 Aug 2024

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
Tri.fr trial

PCRonline @ ESC Congress 2024: the interventional cardiology perspective!

26 Jul 2024

What was new and hot in interventional cardiology at #ESCCongress 2024!

PCRonline @ ESC Congress 2024

The TRI.Fr trial: how will it impact my practice?

19 Jul 2024

Watch the replay of this webinar to get the main results from the TRI-FR trial, along with interventional and heart valve disease specialist interpretations based on the existing evidence!

Prognostic implications of residual tricuspid regurgitation grading after transcatheter tricuspid valve repair

18 Jun 2024

The take-home message for clinicians is that in the treatment of tricuspid regurgitation, the most frequent valvular disease alongside aortic stenosis, redefining procedural success as a function of the residual degree of TR is crucial.

Alessandro Sticchi

Reviewer

Alessandro Sticchi

Reviewer

Federico Bargagna
Prognostic implications of residual tricuspid regurgitation grading after transcatheter tricuspid valve repair

New York Valves 2024: Everything you need to know in a nutshell

11 Jun 2024

Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts. 

Alessandro Sticchi

Author

Alessandro Sticchi
New York Valves 2024: Everything you need to know in a nutshell

A journey through tricuspid regurgitation phenotypes

28 May 2024

Watch the replay of this webinar to learn about secondary tricuspid regurgitation (TR) and management of TR in patients with cardiac implantable electronic devices (CIED) and much more!

A journey through tricuspid regurgitation phenotypes

Patient management before, during, and after transcatheter tricuspid valve replacement

16 May 2024 – From EuroPCR 2024

In this session, explore key aspects of transcatheter tricuspid valve replacement, including the role of right ventricular function, pre-procedural hemodynamics, and factors that contribute to procedural success or failure, and gain insights into patient selection criteria, essential imaging techniques, and best practices for post-procedural care, both...

Patient management before, during, and after transcatheter tricuspid valve replacement

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care

16 May 2024 – From EuroPCR 2024

This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care

Mitral and tricuspid hotline

16 May 2024 – From EuroPCR 2024

This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...

Mitral and tricuspid hotline